Medicine · Genomics
Genomics, precision medicine and advanced biomarkers
Evidence- and risk-based access to emerging molecular diagnostics, with sample collection at SEKO and specialised analysis through accredited external or partner laboratories.
Genomics and precision medicine
- Whole genome or exome sequencing where appropriate
- Pharmacogenomics
- Hereditary risk assessment
- Reproductive genetics
- Selected polygenic-risk approaches where validated
- Selected epigenetic assessments where scientifically appropriate
Advanced biomarkers and molecular diagnostics
- Cardiometabolic biomarkers
- Inflammatory markers
- Hormonal health
- Nutritional biomarkers
- Selected molecular diagnostics
- Emerging liquid-biopsy technologies where scientifically and regulatorily appropriate
Not all analyses are performed in-house. Emerging molecular diagnostics do not replace standard, guideline-based cancer screening.